Analyst Ratings for Biogen Inc. (BIIB)

Updated: 2017-07-28

An average rating of Overweight has been given to Biogen Inc. (NASDAQ:BIIB) by analysts covering the stock. A consensus rating of Overweight was previously issued for BIIB last month.

30 analysts issued ratings on the stock, where 16 gave BIIB a buy rating, 3 gave an overweight rating, 11 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. During this time, the number of analysts bearish on the stock has decreased by 1.

Several price targets were given for BIIB by the analysts covering the stock. The maximum price target given was 442, implying potential capital gains of 53.5 percent. The most pessimistic price target was 270, implying a possible loss of -6.23 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0.47 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 0.47 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 1.59 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.34 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 9 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. Also over the last month, 4 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

BIIB has an estimated earnings growth rate of 35.26 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of BIIB is 0.54.

In the last 52-weeks, BIIB has achieved a high of 307.33 and a low of 244.28. The current market price is above the trailing year's low by 17.88 percent, and 6.31 percent below the high. BIIB has a P/E ratio of 18.91. Investors typically compare the P/E ratio to a company's peers in the industry. The BIIB value stock report compares BIIB to some of its peers using value stock charts. The stock has a market capitalization of $63.15 billion. BIIB will post this quarters earnings in days, on 0000-00-00.